Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial.
Li C, Luo F, Liu C, Xiong N, Xu Z, Zhang W, Yang M, Wang Y, Liu D, Yu C, Zeng J, Zhang L, Li D, Liu Y, Feng M, Liu R, Mei J, Deng S, Zeng Z, He Y, Liu H, Shi Z, Duan M, Kang D, Liao J, Li W, Liu L.
Li C, et al. Among authors: kang d.
Ann Med. 2021 Dec;53(1):391-401. doi: 10.1080/07853890.2021.1890329.
Ann Med. 2021.
PMID: 33620016
Free PMC article.
Clinical Trial.